发明授权
US07829683B2 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
有权
编码修饰的HIV-1 gp41膜多肽的多核苷酸
- 专利标题: Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
- 专利标题(中): 编码修饰的HIV-1 gp41膜多肽的多核苷酸
-
申请号: US11826471申请日: 2007-07-16
-
公开(公告)号: US07829683B2公开(公告)日: 2010-11-09
- 发明人: Pierre-Francois Serres
- 申请人: Pierre-Francois Serres
- 申请人地址: CH Nyon
- 专利权人: Lomastar Technologies Sarl
- 当前专利权人: Lomastar Technologies Sarl
- 当前专利权人地址: CH Nyon
- 代理机构: Oliff & Berridge, PLC
- 优先权: FR9714387 19971117
- 主分类号: A61K39/12
- IPC分类号: A61K39/12
摘要:
A method for obtaining a vaccine against the infection of an animal host by a retrovirus capable of penetrating into a host's target cell, where the target cell possesses a membrane receptor for a protein of the host, by preparing candidate vaccine agents based on a modified polypeptide having at least part of an envelope protein of the retrovirus, where the polypeptide has at least one fragment of an immunodominant region of the envelope protein, the fragment containing at least one conserved amino acid of the immunodominant region present in the pathogenic strain, wherein the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; and selecting as a vaccine such a modified polypeptide chosen from those which induce an immune response directed against said immunodominant region of the envelope protein and not against the protein of the host.
公开/授权文献
信息查询